Company Overview and News

GBM Resources' pending acquisition of Twin Hills project could double Mt Coolon resource

GBM Resources Limited (ASX:GBZ) has entered into a Binding Heads of Agreement with Minjar Gold to acquire the Twin Hills Gold Project located in Queensland.
Upvote Downvote

GBM Gold's pending acquisition of Twin Hills project could double Mt Coolon resource

GBM Gold Ltd’s (ASX:GBZ) has entered into a Binding Heads of Agreement with Minjar Gold to acquire the Twin Hills Gold Project located in Queensland.
Upvote Downvote

GBM Resources Limited takes Mount Coolon Gold Project to the next stage

GBM Resources Limited (ASX:GBZ) is moving forward on its Mount Coolon Gold Project in Queensland by commencing a scoping study.
Upvote Downvote

GBM Resources upgrades gold potential at Mount Coolon

GBM Resources (ASX:GBZ) has revealed a significant increase in resources at the Glen Eva Gold Deposit, part of its Mount Coolon Gold Project in Queensland.
Upvote Downvote

WCB Resources and GBM Resources Terminate Heads of Agreement

2017-03-31 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 31, 2017) - Further to the announcement dated February 16, 2017 WCB Resources Ltd. (TSX VENTURE:WCB) ("WCB" or the "Company") announces the termination of the Heads of Agreement with GBM Resources Ltd (ASX:GBZ) ("GBM") due to the financing conditions (by GBM) for the definitive agreement not being met prior to the deadline of March 31, 2017.
Upvote Downvote

GBM merger canned after funding falls through

Gold explorer GBM Resources has been forced to terminate merger plans with Canadian company WCB Resources after a loan agreement with a funding party fell through.
Upvote Downvote

WCB Resources Clarifies Disclosure

2017-02-17 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 17, 2017) - WCB Resources (TSX VENTURE:WCB) announces that because of differences in Canadian and Australian reporting requirements for mineral projects, it is clarifying certain disclosures in its press release dated February 16, 2017 (the "Press Release"), announcing the execution of a binding heads of agreement with GBM Resources Ltd.
Upvote Downvote

WCB Resources and GBM Resources merger to create a substantial gold development and exploration group

2017-02-16 marketwired
WCB Resources Ltd. (TSX VENTURE:WCB) and GBM Resources Ltd. (ASX:GBZ) are pleased to jointly announce that they have executed a binding HOA to merge the two companies which is to be structured as an Arrangement Agreement under Canadian law . Each WCB shareholder at the record date will receive 8 ordinary shares of GBM for each common share of WCB they hold in consideration for the transfer of those WCB shares to GBM (Merger).
Upvote Downvote

GBM Resources in Canadian merger

Mount Pleasant-based GBM Resources has struck a friendly merger agreement with listed Canadian company WCB Resources, bringing together gold projects in Australia and Papua New Guinea.
Upvote Downvote

GBM Resources in an ASX trading halt

GBM Resources (AXX:GBZ) has been granted a trading halt by the ASX, pending details regarding a proposed corporate transaction.
Upvote Downvote

GBM Resources advancing redevelopment plan for Mt Coolon Gold Project

The company’s share price has increased by 50% during the past week, last trading at $0.021. Stage 1 drilling is on schedule with 19 holes completed for a total of 1,023 metres of drilling. Results have been received for 8 of the 19 holes, with significant assays received to date including: - 3.5 metres at 14.7 g/t gold from 44 metres, including 0.9 metres at 55.7 g/t gold; and - 22 metres at 2.0 g/t gold from 28 metres, including 4.
Upvote Downvote

GBM Resources Ltd to assess near term gold production with drilling

GBM Resources Ltd (ASX:GBZ) is an Australian resources company actively building a gold portfolio of projects within Malaysia and the east coast of Australia.
Upvote Downvote

GBM Resources Ltd pinpoints gold target at Mt Coolon

GBM Resources Ltd (ASX:GBZ) is an Australian resources company actively building a gold portfolio of projects within Malaysia and the east coast of Australia.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...